-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation